Cédrick Lefol

700 total citations
13 papers, 200 citations indexed

About

Cédrick Lefol is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Cédrick Lefol has authored 13 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Pathology and Forensic Medicine and 8 papers in Cancer Research. Recurrent topics in Cédrick Lefol's work include Cancer Genomics and Diagnostics (8 papers), Genetic factors in colorectal cancer (8 papers) and RNA Research and Splicing (4 papers). Cédrick Lefol is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Genetic factors in colorectal cancer (8 papers) and RNA Research and Splicing (4 papers). Cédrick Lefol collaborates with scholars based in France, United States and Monaco. Cédrick Lefol's co-authors include Étienne Rouleau, Rosette Lidereau, Ivan Bièche, Sylviane Olschwang, Florence Coulet, Violaine Bourdon, Florent Soubrier, Hagay Sobol, Tetsuro Noguchi and Catherine Noguès and has published in prestigious journals such as Human Molecular Genetics, Journal of Medical Genetics and Human Mutation.

In The Last Decade

Cédrick Lefol

13 papers receiving 197 citations

Peers

Cédrick Lefol
Julie Rosenbaum United States
Barbara K. Fortini United States
Jonathan Baber Netherlands
Adam Mil-Homens United States
Karin M. Fredrikson United States
Julie Rosenbaum United States
Cédrick Lefol
Citations per year, relative to Cédrick Lefol Cédrick Lefol (= 1×) peers Julie Rosenbaum

Countries citing papers authored by Cédrick Lefol

Since Specialization
Citations

This map shows the geographic impact of Cédrick Lefol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cédrick Lefol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cédrick Lefol more than expected).

Fields of papers citing papers by Cédrick Lefol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cédrick Lefol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cédrick Lefol. The network helps show where Cédrick Lefol may publish in the future.

Co-authorship network of co-authors of Cédrick Lefol

This figure shows the co-authorship network connecting the top 25 collaborators of Cédrick Lefol. A scholar is included among the top collaborators of Cédrick Lefol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cédrick Lefol. Cédrick Lefol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bouras, Ahmed, et al.. (2024). Splicing analysis of 24 potential spliceogenic variants in MMR genes and clinical interpretation based on refined ACMG/AMP criteria. Human Molecular Genetics. 33(10). 850–859. 1 indexed citations
2.
Bouras, Ahmed, et al.. (2023). PMS2 or PMS2CL? Characterization of variants detected in the 3′ of the PMS2 gene. Genes Chromosomes and Cancer. 63(1). e23193–e23193. 4 indexed citations
3.
Bouras, Ahmed, et al.. (2023). From variant of unknown significance to likely pathogenic: Characterization and pathogenicity determination of a large genomic deletion in the MLH1 gene. Molecular Genetics & Genomic Medicine. 11(9). e2231–e2231. 2 indexed citations
4.
Bouras, Ahmed, et al.. (2022). A PMS2 non-canonical splicing site variant leads to aberrant splicing in a patient suspected for lynch syndrome. Familial Cancer. 22(3). 303–306. 1 indexed citations
5.
Lefol, Cédrick, Emilie Sohier, Christian Baudet, et al.. (2020). Acquired somatic MMR deficiency is a major cause of MSI tumor in patients suspected for “Lynch-like syndrome” including young patients. European Journal of Human Genetics. 29(3). 482–488. 16 indexed citations
6.
Wang, Qing, Julie Leclerc, Gaëlle Bougeard, et al.. (2020). Characterisation of heterozygous PMS2 variants in French patients with Lynch syndrome. Journal of Medical Genetics. 57(7). 487–499. 8 indexed citations
7.
Dadone, Bérengère, Damien Ambrosetti, C. Baudoin, et al.. (2015). Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases. Genes Chromosomes and Cancer. 54(6). 369–382. 32 indexed citations
8.
Cheeseman, Kevin, Étienne Rouleau, Anne Vannier, et al.. (2012). A diagnostic genetic test for the physical mapping of germline rearrangements in the susceptibility breast cancer genes BRCA1 and BRCA2. Human Mutation. 33(6). 998–1009. 15 indexed citations
9.
Muller, Danièle, Étienne Rouleau, Sandrine M. Caputo, et al.. (2011). An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition. BMC Medical Genetics. 12(1). 121–121. 15 indexed citations
10.
Rouleau, Étienne, Hélène Zattara, Cédrick Lefol, et al.. (2011). First large rearrangement in the MUTYH gene and attenuated familial adenomatous polyposis syndrome. Clinical Genetics. 80(3). 301–303. 12 indexed citations
11.
Coulet, Florence, Étienne Rouleau, Cédrick Lefol, et al.. (2010). A One-Step Prescreening for Point Mutations and Large Rearrangement in BRCA1 and BRCA2 Genes Using Quantitative Polymerase Chain Reaction and High-Resolution Melting Curve Analysis. Genetic Testing and Molecular Biomarkers. 14(5). 677–690. 16 indexed citations
13.
Rouleau, Étienne, Cédrick Lefol, Sengül Tozlu, et al.. (2007). High‐resolution oligonucleotide array‐CGH applied to the detection and characterization of large rearrangements in the hereditary breast cancer gene BRCA1. Clinical Genetics. 72(3). 199–207. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026